SEC Form 4 · accession 0000921895-16-004862
Actinium Pharmaceuticals, Inc. · ATNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Jun 2, 2016
Accepted (ET)
Jun 6, 2016 · 7:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 2, 2016 | S | 11,000 | $2.00 | D | 5,196,395 | D | |
| Common Stock | Jun 2, 2016 | S | 6,790 | $2.02 | D | 5,189,605 | D |
Table II — derivative securities
No Table II lines on this filing.